MedCodeSearch
ICD-10-CM Current in FY 2027

Z79.810

Long term (current) use of selective estrogen receptor modulators (SERMs)

Release
FY 2027
Effective
Official source (opens in a new tab)

Hierarchy

Where Z79.810 sits in the official hierarchy. Each level is the code it is classified under.

  1. Z79 Long term (current) drug therapy
  2. Z79.8 Other long term (current) drug therapy
  3. Z79.81 Parent Long term (current) use of agents affecting estrogen receptors and estrogen levels
  4. Z79.810 This code Long term (current) use of selective estrogen receptor modulators (SERMs)

Official Coding Notes

Reproduced verbatim from the FY 2027 ICD-10-CM files. Notes labelled as inherited are declared on a parent code and apply here too.

Includes

long term (current) drug use for prophylactic purposes

Inherited from Z79 — Long term (current) drug therapy

Inclusion Terms

Long term (current) use of raloxifene (Evista)

Inclusion Terms

Long term (current) use of tamoxifen (Nolvadex)

Inclusion Terms

Long term (current) use of toremifene (Fareston)

Excludes1

hormone replacement therapy ( Z79.890 )

Inherited from Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels

Excludes2

drug abuse and dependence (F11-F19)

Inherited from Z79 — Long term (current) drug therapy

Excludes2

drug use complicating pregnancy, childbirth, and the puerperium ( O99.32- )

Inherited from Z79 — Long term (current) drug therapy

Code First

, if applicable:

Inherited from Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels

Code First

malignant neoplasm of breast ( C50 .-)

Inherited from Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels

Code First

malignant neoplasm of prostate ( C61 )

Inherited from Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels

Use Additional Code

code, if applicable, to identify:

Inherited from Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels

Use Additional Code

estrogen receptor positive status ( Z17.0 )

Inherited from Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels

Use Additional Code

family history of breast cancer ( Z80.3 )

Inherited from Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels

Use Additional Code

genetic susceptibility to malignant neoplasm (cancer) ( Z15.0- )

Inherited from Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels

Use Additional Code

personal history of breast cancer ( Z85.3 )

Inherited from Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels

Use Additional Code

personal history of prostate cancer ( Z85.46 )

Inherited from Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels

Use Additional Code

postmenopausal status ( Z78.0 )

Inherited from Z79.81 — Long term (current) use of agents affecting estrogen receptors and estrogen levels

Code Also

any therapeutic drug level monitoring ( Z51.81 )

Inherited from Z79 — Long term (current) drug therapy

Version History

How Z79.810 appears in each release imported from the official files, newest first.

  1. FY 2027 Effective

    Current

    Long term (current) use of selective estrogen receptor modulators (SERMs)

  2. FY 2026 Effective

    Unchanged

    Long term (current) use of selective estrogen receptor modulators (SERMs)

Related Codes

Other codes under Z79.81

Data Source

Code information on this page is derived from the FY 2027 ICD-10-CM files published by CDC NCHS and CMS.

Release
FY 2027
Effective
Source file
icd10cm-code-descriptions-2027.zip

Official ICD-10-CM source files (opens in a new tab)

MedCodeSearch is an independent reference service and is not affiliated with CMS, CDC, or the U.S. government.

Look up another code

Search ICD-10-CM, ICD-10-PCS and HCPCS Level II by code or description.